Johnson and Johnson 2015 Annual Report Download - page 72

Download and view the complete annual report

Please find page 72 of the 2015 Johnson and Johnson annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 112

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112

A summary of the restricted share units and performance share units activity under the Plans as of January 3, 2016 is
presented below:
(Shares in Thousands)
Outstanding
Restricted
Share Units
Outstanding
Performance
Share Units
Shares at December 30, 2012 31,834 285
Granted 10,582 1,290
Issued (10,078) –
Canceled/forfeited (1,721) (40)
Shares at December 29, 2013 30,617 1,535
Granted 8,487 1,113
Issued (9,685) (19)
Canceled/forfeited (1,726) (98)
Shares at December 28, 2014 27,693 2,531
Granted 7,637 931
Issued (10,164) (285)
Canceled/forfeited (1,281) (99)
Shares at January 3, 2016 23,885 3,078
The average fair value of the restricted share units granted was $91.65, $83.01 and $65.90 in 2015, 2014 and 2013,
respectively, using the fair market value at the date of grant. The fair value of restricted share units was discounted for
dividends, which are not paid on the restricted share units during the vesting period. The fair value of restricted share units
issued was $597.6 million, $541.0 million and $569.2 million in 2015, 2014 and 2013, respectively.
The weighted average fair value of the performance share units granted was $93.54, $85.94 and $73.42 in 2015, 2014 and
2013, calculated using the weighted average fair market value for each of the three component goals at the date of grant.
The fair values for the sales and earnings per share goals of each performance share unit were estimated on the date of
grant using the fair market value of the shares at the time of the award discounted for dividends, which are not paid on the
performance share units during the vesting period. The fair value for the relative total shareholder return goal of each
performance share unit was estimated on the date of grant using the Monte Carlo valuation model. The fair value of
performance share units issued was $16.7 million and $1.4 million in 2015 and 2014, respectively. No performance share
units vested in 2013.
18. Segments of Business and Geographic Areas
Sales to Customers
(Dollars in Millions) 2015 2014 2013
Consumer –
United States $5,222 5,096 5,162
International 8,285 9,400 9,535
Total 13,507 14,496 14,697
Pharmaceutical –
United States 18,333 17,432 13,948
International 13,097 14,881 14,177
Total 31,430 32,313 28,125
Medical Devices –
United States 12,132 12,254 12,800
International 13,005 15,268 15,690
Total 25,137 27,522 28,490
Worldwide total $70,074 74,331 71,312
60 •Johnson & Johnson 2015 Annual Report